Printed From:

DISCOVER MORE ABOUT ATOPIC DERMATITIS

transcript ▼
transcript ▼
transcript ▼
transcript ▼
transcript ▼
transcript ▼
transcript ▼
transcript ▼

HCPs WITH ATOPIC DERMATITIS

EXPERTS IN THE FIELD

This educational program has been developed by Regeneron Pharmaceuticals and Sanofi Genzyme. The speakers have been compensated for their time and effort.

These videos have increased my general knowledge of atopic dermatitis

TAKE THE CHALLENGE

This quiz is only for market research purposes in the United States. You are not required to answer any of the following questions, and your answers will remain anonymous.

1. Which of the following subclinical defects does nonlesional skin exhibit?

Nonenonlesional skin is normal skin
Increased epidermal thickness
Ongoing inflammation
Increased epidermal thickness and ongoing inflammation

2. Chronic skin inflammation is a source of:

Itch-scratch cycle
Lesions and itch
Primary signs and symptoms of atopic dermatitis
All of the above

3. Nonlesional skin in patients with atopic dermatitis is not histologically normal.

True
False

4. Which Th2 cytokines are key drivers involved with the underlying inflammatory process of atopic dermatitis?

TNF-α
IL-4
IL-13
IL-4 and IL-13

5. Th2-mediated inflammation in atopic dermatitis can:

Weaken the skin barrier
Create susceptibility to xerosis
Lead to highly pruritic lesion formation
All of the above

6. Some patients with atopic dermatitis are often trapped in an endless cycle of frequent, unpredictable flares that last days to weeks, along with persistent itching and lesions.

True
False

7. A proactive approach is warranted for the management of atopic dermatitis.

True
False